Relationship between kalemia and intensive care unit admission or death in hospitalized COVID-19 patients: A cohort study.

ABSTRACT:

Background

SARS-CoV-2 uses Angiotensin-Converting Enzyme 2 as a viral gateway to the cell and could interact with the renin-angiotensin-aldosterone system. Other studies have shown kalemia abnormalities in patients with severe forms of coronavirus disease 2019. Our goal was to assess the prognosis value of kalemia within ten days of symptom offset in the COVID-19 hospitalized population.

Methods

We analyzed data from a prospective cohort that included 65 patients with COVID-19, admitted between March 15, 2020, and March 21, 2020. The study aimed at determining the relationship between baseline kalemia and the admission to an intensive care unit (ICU) or death.

Results

The median age of the patients was 65 [54-79] years old, and 66.2% of the patients were men. Baseline

SUBMITTER: Guedon AF 

PROVIDER: S-EPMC8557982 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature